StrategicPartnershipsNon-DilutiveFundingCorporateSpinoutsCSABMembers?GeneYeo,Ph.D.TargetedTherapeutic(Asset)FinancingDiversity$12.3MillionNIDAGrantARCHVenturePartnersMDAndersonCancerCenter1.02DPISundarKodiyalamTop-tierInvestorsMagnoliaNeurosciencesOperatingPartners?BruceL.A.Carter,Ph.D.SteveGillis,Ph.D.GatesFoundationPfizerVenturesPronirasAI &MachineLearningSubstantialExitHistoryAlexandriaVentureInvestmentsTheRockefellerUniversityExceptionalTrackRecordAdvisory&CorporateBoardsJanLundberg,Ph.D.WuXiPharmaTechWeillCornellMedicineUTSouthwesternMedicalCenterOncologyEliLilly(BARDA)– onupdatedslide deckSingaporeOfficeLydianNeurosciences150+Years’ExperienceApogenBiotechnologiesLeroyHood,M.D.,Ph.D.Neuroscience& NeurologyLodoTherapeuticsPetraPharmaSeattleOfficeTachiYamada,M.D.$3.375BillionExit$1 BillionGenentechCollaborationReviewed >4,000OpportunitiesCPRIT2014 Top-quartileRankedHarvardMedicalSchoolCaseWesternReserveAbbvieUniversityofMinnesotaTemasekDanaFarberCancerNewYorkOfficeSyndicationPartnersDivestituresScientificExpertiseSanDiegoOfficeTurn-KeyFacilitiesAcademic&ResearchInstitutionsEntrepreneursRodeoTherapeuticsScientists&TechnologyDevelopersUniformedServicesUniversityEmployeesPennState2.85DVPICapital-efficiencyWRFCapital58.43%IRRColumbiaUniversityStrategicPartnershipsNon-DilutiveFundingCorporateSpinoutsCSABMembers?GeneYeo,Ph.D.TargetedTherapeutic(Asset)FinancingDiversity$12.3MillionNIDAGrantARCHVenturePartnersMDAndersonCancerCenter1.02DPISundarKodiyalamTop-tierInvestorsMagnoliaNeurosciencesOperatingPartners?BruceL.A.Carter,Ph.D.SteveGillis,Ph.D.GatesFoundationPfizerVenturesPronirasAI &MachineLearningSubstantialExitHistoryAlexandriaVentureInvestmentsTheRockefellerUniversityExceptionalTrackRecordAdvisory&CorporateBoardsJanLundberg,Ph.D.WuXiPharmaTechWeillCornellMedicineUTSouthwesternMedicalCenterOncologyEliLilly(BARDA)– onupdatedslide deckSingaporeOfficeLydianNeurosciences150+Years’ExperienceApogenBiotechnologiesLeroyHood,M.D.,Ph.D.Neuroscience& NeurologyLodoTherapeuticsPetraPharmaSeattleOfficeTachiYamada,M.D.$3.375BillionExit$1 BillionGenentechCollaborationReviewed >4,000OpportunitiesCPRIT2014 Top-quartileRankedHarvardMedicalSchoolCaseWesternReserveAbbvieUniversityofMinnesotaTemasekDanaFarberCancerNewYorkOfficeSyndicationPartnersDivestituresScientificExpertiseSanDiegoOfficeTurn-KeyFacilitiesAcademic&ResearchInstitutionsEntrepreneursRodeoTherapeuticsScientists&TechnologyDevelopersUniformedServicesUniversityEmployeesPennState2.85DVPICapital-efficiencyWRFCapital58.43%IRRColumbiaUniversity

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
G
2
O
3
G
4
B
5
I
6
O
7
N
8
O
9
O
10
I
11
O
12
B
13
B
14
I
15
I
16
N
17
G
18
B
19
I
20
B
21
G
22
I
23
B
24
N
25
I
26
I
27
G
28
G
29
B
30
G
31
I
32
G
33
B
34
N
35
N
36
B
37
G
38
O
39
N
40
I
41
N
42
O
43
O
44
G
45
O
46
B
47
N
48
O
49
N
50
I
51
I
52
B
53
O
54
I
55
G
56
N
57
O
58
N
59
B
60
G
61
B
62
I
63
O
64
N
65
G
66
I
67
N
68
B
69
B
70
N
71
G
72
O
  1. G-Strategic Partnerships
  2. O-Non-Dilutive Funding
  3. G-Corporate Spinouts
  4. B-CSAB Members?
  5. I-Gene Yeo, Ph.D.
  6. O-Targeted Therapeutic (Asset) Financing
  7. N-Diversity
  8. O-$12.3 Million NIDA Grant
  9. O-ARCH Venture Partners
  10. I-MD Anderson Cancer Center
  11. O-1.02 DPI
  12. B-Sundar Kodiyalam
  13. B-Top-tier Investors
  14. I-Magnolia Neurosciences
  15. I-Operating Partners?
  16. N-Bruce L.A. Carter, Ph.D.
  17. G-Steve Gillis, Ph.D.
  18. B-Gates Foundation
  19. I-Pfizer Ventures
  20. B-Proniras
  21. G-AI & Machine Learning
  22. I-Substantial Exit History
  23. B-Alexandria Venture Investments
  24. N-The Rockefeller University
  25. I-Exceptional Track Record
  26. I-Advisory & Corporate Boards
  27. G-Jan Lundberg, Ph.D.
  28. G-WuXi PharmaTech
  29. B-Weill Cornell Medicine
  30. G-UT Southwestern Medical Center
  31. I-Oncology
  32. G-Eli Lilly
  33. B-(BARDA) – on updated slide deck
  34. N-Singapore Office
  35. N-Lydian Neurosciences
  36. B-150+ Years’ Experience
  37. G-Apogen Biotechnologies
  38. O-Leroy Hood, M.D., Ph.D.
  39. N-Neuroscience & Neurology
  40. I-Lodo Therapeutics
  41. N-Petra Pharma
  42. O-Seattle Office
  43. O-Tachi Yamada, M.D.
  44. G-$3.375 Billion Exit
  45. O-$1 Billion Genentech Collaboration
  46. B-Reviewed > 4,000 Opportunities
  47. N-CPRIT
  48. O-2014 Top-quartile Ranked
  49. N-Harvard Medical School
  50. I-Case Western Reserve
  51. I-Abbvie
  52. B-University of Minnesota
  53. O-Temasek
  54. I-Dana Farber Cancer
  55. G-New York Office
  56. N-Syndication Partners
  57. O-Divestitures
  58. N-Scientific Expertise
  59. B-San Diego Office
  60. G-Turn-Key Facilities
  61. B-Academic & Research Institutions
  62. I-Entrepreneurs
  63. O-Rodeo Therapeutics
  64. N-Scientists & Technology Developers
  65. G-Uniformed Services University
  66. I-Employees
  67. N-Penn State
  68. B-2.85 DVPI
  69. B-Capital-efficiency
  70. N-WRF Capital
  71. G-58.43% IRR
  72. O-Columbia University